title: Pharmacokinetics of iothalamate in endstage renal disease.
abstract: Some nephrologists make alterations in routine peritoneal and hemodialysis schedules after diagnostic studies that use radiographic contrast agents. A study to determine the pharmacokinetics of one contrast agent, iothalamate, is reported. The plasma (total body) clearance of iothalamate was measured in seven patients who had endstage renal disease (ESRD) and who received maintenance hemodialysis. During an interdialytic period, plasma clearance of iothalamate varied from 0.7 to 5.2 mL/min (3.1 +/- 1.8 mL/min, mean +/- SD) with an elimination rate constant (beta) of 0.0164 +/- 0.01 hr-1, a terminal half-life of 61 +/- 42 hours, and an estimated distribution volume of 11 +/- 3.9 L. Hemodialysis clearance of iothalamate was 104 +/- 54 mL/min. With the assumption that iothalamate is mainly distributed in the extracellular fluid (ECF) compartment, the theoretical fluid shift from the intracellular fluid (ICF) compartment to the ECF compartment was 323 mL after administration of the largest dose (2.1 mL/kg or 1.6 mmol/kg of body weight) of 60% meglumine iothalamate solution. The average maximum serum osmolarity change was less than expected, suggesting some type of internal buffering of meglumine iothalamate. In the first few hours after radiocontrast administration in four patients, the average change in serum osmolarity was 5 mmol/L; the average change in serum sodium concentration during this same time was a decrease of 0.5 mmol/L. The minor increase in ECF volume induced by hyperosmolar contrast agents does not require immediate dialysis in most patients. When needed, however, for contrast-related adverse effects, hemodialysis is efficient in rapidly removing iothalamate.
authors.affiliation: Department of Medicine, Loma Linda University School of Medicine, California.
authors.forename: J R
authors.initials: JR
authors.lastname: Evans
authors.forename: R E
authors.initials: RE
authors.lastname: Cutler
authors.forename: S C
authors.initials: SC
authors.lastname: Forland
mesh_terms: D000368:Aged; D006801:Humans; D007457:Iodine Radioisotopes; D007483:Iothalamic Acid / Q000493:pharmacokinetics*; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D008875:Middle Aged; D009994:Osmolar Concentration; D006435:Renal Dialysis; D012964:Sodium / Q000097:blood
chemical_list: D007457:Iodine Radioisotopes; D007483:Iothalamic Acid; D012964:Sodium